• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1975年和1994年世界卫生组织子宫内膜增生分类的可重复性比较。

Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia.

作者信息

Skov B G, Broholm H, Engel U, Franzmann M B, Nielsen A L, Lauritzen A F, Skov T

机构信息

Department of Pathology, Frederiksberg Hospital, Denmark.

出版信息

Int J Gynecol Pathol. 1997 Jan;16(1):33-7. doi: 10.1097/00004347-199701000-00006.

DOI:10.1097/00004347-199701000-00006
PMID:8986530
Abstract

In a blinded, randomized design, six histopathologists with an interest in gynecological pathology examined the inter- and intraobserver variation of the histopathological diagnosis of endometrial hyperplasia according to the World Health Organization (WHO) classification of 1975 and the new WHO classification of 1994. On four occasions, the pathologists assessed hematoxylin/eosin-stained slides from 128 cases originally diagnosed and coded in the Snomed system as endometrial hyperplasia. In the first and third rounds, the slides were classified according to the 1975 classification and in the second and fourth rounds according to the 1994 classification. The overall interobserver agreement in the two rounds where the 1975 classification was used was 0.47 and 0.51, and the kappa values 0.24 [95% confidence interval (CI) 0.21-0.27] and 0.30 (95% CI 0.27-0.33). The overall interobserver agreement in the two rounds using the 1994 classification was 0.45 and 0.41 and the kappa values 0.25 (95% CI 0.23-0.28) and 0.20 (95% CI 0.17-0.22). Reducing the classification to two categories with clinical significance (atypical endometrial hyperplasia versus others in the 1975 classification, and atypical endometrial hyperplasia, complex versus others in the 1994 classification) increased the overall agreement of the 1975 classification in both rounds to 0.91 and of the 1994 classification to 0.92 and 0.90. The kappa values increased to 0.54 (95% CI 0.49-0.58) and 0.49 (95% CI 0.45-0.54) in the 1975 classification and to 0.59 (95% CI 0.54-0.63) and 0.42 (95% CI 0.37-0.46) in the 1994 classification. The intraobserver overall agreement for the 1975 classification ranged from 0.80 to 0.55 and the kappa values from 0.70 (95% CI 0.58-0.81) to 0.28 (95% CI 0.17-0.39). The intraobserver overall agreement for the 1994 classification ranged from 0.71 to 0.46 and the kappa values from 0.60 (95% CI 0.51-0.70) to 0.20 (95% CI 0.09-0.30). It is concluded that there is considerable inter- and intraobserver variation using both the 1975 and the 1994 classifications of endometrial hyperplasia. We propose that there is need for a specification and for a simplification of the classification.

摘要

在一项双盲随机设计中,六位对妇科病理学感兴趣的组织病理学家,根据1975年世界卫生组织(WHO)分类标准和1994年WHO新分类标准,检查了子宫内膜增生组织病理学诊断的观察者间及观察者内差异。病理学家分四次评估了128例最初在Snomed系统中诊断并编码为子宫内膜增生的苏木精/伊红染色切片。在第一轮和第三轮中,切片根据1975年分类标准进行分类,在第二轮和第四轮中根据1994年分类标准进行分类。在使用1975年分类标准的两轮评估中,观察者间总体一致性分别为0.47和0.51,kappa值分别为0.24[95%置信区间(CI)0.21 - 0.27]和0.30(95%CI 0.27 - 0.33)。在使用1994年分类标准的两轮评估中,观察者间总体一致性分别为0.45和0.41,kappa值分别为0.25(95%CI 0.23 - 0.28)和0.20(95%CI 0.17 - 0.22)。将分类简化为具有临床意义的两类(1975年分类标准中的非典型子宫内膜增生与其他类型,以及1994年分类标准中的非典型子宫内膜增生、复杂性增生与其他类型)后,1975年分类标准在两轮评估中的总体一致性均提高到0.91,1994年分类标准在两轮评估中的总体一致性分别提高到0.92和0.90。1975年分类标准的kappa值分别提高到0.54(95%CI 0.49 - 0.58)和0.49(95%CI 0.45 - 0.54),1994年分类标准的kappa值分别提高到0.59(95%CI 0.54 - 0.63)和0.42(95%CI 0.37 - 0.46)。1975年分类标准的观察者内总体一致性范围为0.80至0.55,kappa值范围为0.70(95%CI 0.58 - 0.81)至0.28(95%CI 0.17 - 0.39)。1994年分类标准的观察者内总体一致性范围为0.71至0.46,kappa值范围为0.60(95%CI 0.51 - 0.70)至0.20(95%CI 0.09 - 0.30)。结论是,使用1975年和1994年子宫内膜增生分类标准时,观察者间及观察者内均存在相当大的差异。我们建议需要对分类进行规范和简化。

相似文献

1
Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia.1975年和1994年世界卫生组织子宫内膜增生分类的可重复性比较。
Int J Gynecol Pathol. 1997 Jan;16(1):33-7. doi: 10.1097/00004347-199701000-00006.
2
A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens.一项欧洲多中心研究,旨在测试世界卫生组织子宫内膜增生分类的可重复性,并提出针对活检和刮宫标本的简化工作分类建议。
Am J Surg Pathol. 1999 Sep;23(9):1102-8. doi: 10.1097/00000478-199909000-00014.
3
Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia.使用贝叶斯信念网络对子宫内膜增生进行分类的专家系统支持。
J Pathol. 2002 Jul;197(3):403-14. doi: 10.1002/path.1135.
4
Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification.当前子宫内膜样腺性增殖分类的可重复性:支持简化分类的进一步证据。
Histopathology. 2014 Jan;64(2):284-92. doi: 10.1111/his.12249. Epub 2013 Sep 20.
5
Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology.利用液基细胞学对子宫内膜病变诊断的形态学及可重复性研究。
Cancer. 2005 Apr 25;105(2):56-64. doi: 10.1002/cncr.21025.
6
Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.确定子宫内膜刮除术标本中子宫内膜增生亚组及高分化子宫内膜样癌诊断的观察者间和观察者内重复性。
Arch Iran Med. 2009 Jul;12(4):377-82.
7
Inter-observer reproducibility of endometrial cytology by the Osaki Study Group method: utilising the Becton Dickinson SurePath liquid-based cytology.大崎研究组方法对子宫内膜细胞学进行观察者间再现性研究:采用贝克顿·迪金森公司的SurePath液基细胞学技术
Cytopathology. 2016 Dec;27(6):472-478. doi: 10.1111/cyt.12342. Epub 2016 Apr 25.
8
Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.子宫内膜增生、非典型增生和高分化癌诊断的可重复性。
Am J Surg Pathol. 1998 Aug;22(8):1012-9. doi: 10.1097/00000478-199808000-00012.
9
Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.非典型子宫内膜增生诊断的可重复性:一项妇科肿瘤学组的研究
Cancer. 2006 Feb 15;106(4):804-11. doi: 10.1002/cncr.21649.
10
Diagnosing endometrial hyperplasia: why is it so difficult to agree?诊断子宫内膜增生:为何难以达成共识?
Am J Surg Pathol. 2008 May;32(5):691-8. doi: 10.1097/PAS.0b013e318159a2a0.

引用本文的文献

1
Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.子宫内膜的连续基因组分析支持组织学上不可区分的子宫内膜癌前体的存在。
J Pathol. 2021 May;254(1):20-30. doi: 10.1002/path.5628. Epub 2021 Mar 9.
2
Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer.同时傅里叶变换红外光谱和拉曼光谱在子宫内膜非典型增生和癌症中的应用。
Int J Mol Sci. 2020 Jul 8;21(14):4828. doi: 10.3390/ijms21144828.
3
miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia.
微小RNA作为准确检测非典型子宫内膜增生/子宫内膜上皮内瘤变的候选生物标志物
Front Oncol. 2019 Jun 21;9:526. doi: 10.3389/fonc.2019.00526. eCollection 2019.
4
New concepts for an old problem: the diagnosis of endometrial hyperplasia.一个老问题的新概念:子宫内膜增生的诊断。
Hum Reprod Update. 2017 Mar 1;23(2):232-254. doi: 10.1093/humupd/dmw042.
5
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.孕激素治疗抵抗和子宫内膜增生进展的生物标志物。
Am J Obstet Gynecol. 2012 Jul;207(1):36.e1-8. doi: 10.1016/j.ajog.2012.05.012. Epub 2012 May 16.
6
PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.免疫组织化学检测到 PAX2 缺失发生在子宫内膜增生的早期且频繁。
Int J Gynecol Pathol. 2012 Mar;31(2):151-159. doi: 10.1097/PGP.0b013e318226b376.
7
Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy.复杂性增生伴不伴非典型:孕激素治疗的临床结局和意义。
Obstet Gynecol. 2010 Aug;116(2 Pt 1):365-373. doi: 10.1097/AOG.0b013e3181e93330.
8
Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.WHO 分类与子宫内膜上皮内瘤变分类在预测子宫内膜增生中并存恶性肿瘤的存在方面的比较。
J Gynecol Oncol. 2010 Jun;21(2):97-101. doi: 10.3802/jgo.2010.21.2.97. Epub 2010 Jun 30.
9
Incidence of endometrial hyperplasia.子宫内膜增生的发病率。
Am J Obstet Gynecol. 2009 Jun;200(6):678.e1-6. doi: 10.1016/j.ajog.2009.02.032. Epub 2009 Apr 23.
10
Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran.伊朗刮宫标本中 WHO 子宫内膜增生/高分化腺癌分类的可重复性测定及其与计算机形态计量学数据的比较。
Diagn Pathol. 2009 Mar 25;4:10. doi: 10.1186/1746-1596-4-10.